Protagenic Therapeutics Inc (NASDAQ:PTIX) price closed lower on Tuesday, May 20, and dropping -38.02% below its previous close.
A look at the daily price movement shows that the last close reads $11.10, with intraday deals fluctuated between $6.4 and $9.86. Taking into account the 52-week price action we note that the stock hit a 52-week high of $26.18 and 52-week low of $2.35. The stock added 135.13% on its value in the past month.
Protagenic Therapeutics Inc, which has a market valuation of $4.05 million, is expected to release its quarterly earnings report in June.
Technical indicators in stocks provide crucial insights into market trends, guiding investors with precise entry and exit points based on price movements for informed decision-making.On the technical perspective front, indicators give PTIX a short term outlook of 50% Sell on average. Looking at the stock’s medium term indicators we note that it is averaging as a 50% Sell, while an average of long term indicators are currently assigning the stock as 50% Buy.
The overview shows that PTIX’s price is at present 84.01% off the SMA20 and 82.83% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 59.96, with weekly volatility standing at 43.59%. The indicator jumps to 23.45% when calculated based on the past 30 days. Protagenic Therapeutics Inc (NASDAQ:PTIX)’s beta value is holding at 0, while the average true range (ATR) indicator is currently reading 1.58.
An analysis of the Protagenic Therapeutics Inc (NASDAQ:PTIX) stock in terms of its daily trading volume indicates that the 3-month average is 2.02 million. However, this figure increases on the past 10-day timeline to an average of 10.31 million.
Current records show that the company has 0.54M in outstanding shares. The insiders’ percentage holdings are 13.43% of outstanding shares while the percentage share held by institutions stands at 7.01%. The stats also highlight that short interest as of 2025-04-30, stood at 16929.0 shares, which puts the short ratio at the time at 0.02. From this we can glean that short interest is 360.00 of company’s current outstanding shares. Notably, we see that shares short in April rose slightly given the previous month’s figure stood at 5031.0. But the 0.29% upside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
